Get the Stockscreener App
3.3979
8.41%
-0.3121
After Hours:
3.13
-0.2679
-7.88%
Abpro Holdings Inc stock is traded at $3.3979, with a volume of 15,569.
It is down -8.41% in the last 24 hours and up +0.00% over the past month.
Abpro Holdings Inc is a biotechnology company dedicated to developing next-generation antibody therapeutics with the goal of improving the lives of patients with severe and life-threatening diseases. It is focused on novel antibody constructs for immuno-oncology and ophthalmology. By leveraging its proprietary DiversImmune and MultiMabTM antibody discovery and engineering platforms, The company is developing a pipeline of next-generation antibodies, both independently and through collaborations with global pharmaceutical and research institutions.
See More
Previous Close:
$3.71
Open:
$3.3
24h Volume:
15,569
Relative Volume:
12.76
Market Cap:
$169.83M
Revenue:
-
Net Income/Loss:
$-8.09M
P/E Ratio:
-
EPS:
-
Net Cash Flow:
$-8.31M
1W Performance:
+0.00%
1M Performance:
+0.00%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1-Day Range:
$3.18
$3.60
1-Week Range:
$3.18
$4.645
52-Week Range:
$3.18
$4.645
Abpro Holdings Inc Stock (ABP) Company Profile
Compare ABP with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
| ABP | 3.3979 | 169.83M | 0 | -8.09M | -8.31M | 0.00 |
| LION | 6.55 | 1.91B | 3.13B | 50.80M | 555.00M | 0.00 |
| OBDE | 14.69 | 1.81B | 273.87M | 247.73M | -483.02M | 0.00 |
| AACT | 10.89 | 680.63M | 0 | 16.92M | -1.35M | 0.00 |
| ANSC | 10.42 | 449.36M | 0 | 1.30M | 0 | 0.00 |
| EQV | 9.92 | 442.16M | 0 | 0 | 0 | 0.00 |
Abpro Holdings Inc Stock (ABP) Latest News
Abpro Announces Closing of Business Combination with Atlantic Coastal Acquisition Corp. II - PR Newswire
Abpro Holdings Completes Merger, Starts Nasdaq Trading - TipRanks
Atlantic Coastal Acquisition Corp. II Approves Business Combination with Abpro Corporation - Defense World
Atlantic Coastal Acquisition Corp. II Corrects Typographical Error in Previous Reports on Business Combination with Abpro - Defense World
NASDAQ – Stock Price, Charts and News Today - BNN Bloomberg
Antibody biotech Abpro taps SPAC to get back on Nasdaq track 5 years after axed IPO - Fierce Biotech
Abpro to Become Publicly Traded via Merger with Atlantic Coastal Acquisition Corp. II - Business Wire
Abpro Holdings Inc Stock (ABP) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.00%
0.10%
Cap:
|
Volume (24h):